statistiche ricercatore

Continente	#
EU - Europa	430
AS - Asia	333
NA - Nord America	295
SA - Sud America	28
Continente sconosciuto - Info sul continente non disponibili	28
AF - Africa	18
OC - Oceania	6
Totale	1.138

Nazione	#
US - Stati Uniti d'America	286
IT - Italia	220
SG - Singapore	99
RU - Federazione Russa	97
CN - Cina	58
VN - Vietnam	48
BD - Bangladesh	27
HK - Hong Kong	25
BR - Brasile	20
FR - Francia	17
GB - Regno Unito	17
MY - Malesia	15
DE - Germania	13
IE - Irlanda	12
IN - India	12
KR - Corea	12
NL - Olanda	11
FI - Finlandia	10
ZA - Sudafrica	8
JP - Giappone	7
SE - Svezia	6
ES - Italia	5
IR - Iran	5
SA - Arabia Saudita	5
AR - Argentina	4
AU - Australia	4
CA - Canada	4
BE - Belgio	3
IL - Israele	3
KE - Kenya	3
MX - Messico	3
NG - Nigeria	3
PK - Pakistan	3
RO - Romania	3
TH - Thailandia	3
TW - Taiwan	3
AT - Austria	2
AZ - Azerbaigian	2
BA - Bosnia-Erzegovina	2
EE - Estonia	2
EG - Egitto	2
NO - Norvegia	2
NZ - Nuova Zelanda	2
PH - Filippine	2
PT - Portogallo	2
SK - Slovacchia (Repubblica Slovacca)	2
AL - Albania	1
AM - Armenia	1
BY - Bielorussia	1
CO - Colombia	1
CR - Costa Rica	1
DZ - Algeria	1
EC - Ecuador	1
HN - Honduras	1
ID - Indonesia	1
IQ - Iraq	1
JO - Giordania	1
MD - Moldavia	1
PL - Polonia	1
UG - Uganda	1
UY - Uruguay	1
VE - Venezuela	1
Totale	1.110

Nome	#
A multi-modal approach for cancer treatment: pre-clinical study of anti-tumoral and immunomodulatory efficacy of a demethylated cell-based vaccine combined with α-CTLA4 and decitabine	290
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches	241
Epigenetic immune remodeling of mesothelioma cells: A new strategy to improve the efficacy of immunotherapy	201
DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy	123
The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets	109
Abstract 4841: DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy	107
Abstract 2632: A new paradigm for brain tumors treatment: Guadecitabine as a fundamental player to improve tumor immune response	67
Totale	1.138

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	6	0	0	0	0	0	0	0	0	0	0	3	3
2022/2023	26	1	1	5	2	0	4	1	1	3	1	5	2
2023/2024	50	1	1	0	1	1	9	11	1	8	7	4	6
2024/2025	217	8	7	7	38	15	12	6	11	25	18	32	38
2025/2026	754	43	29	44	70	166	40	80	36	44	64	58	80
2026/2027	85	50	18	17	0	0	0	0	0	0	0	0	0
Totale													1.138